Colin J. Meyer
2017
In 2017, Colin J. Meyer earned a total compensation of $2.1M as Chief Medical Officer at REATA PHARMACEUTICALS, a 23% decrease compared to previous year.
Compensation breakdown
| Bonus | $200,000 |
|---|---|
| Option Awards | $1,483,537 |
| Salary | $400,000 |
| Total | $2,083,537 |
Meyer received $1.5M in option awards, accounting for 71% of the total pay in 2017.
Meyer also received $200K in bonus and $400K in salary.
Rankings
In 2017, Colin J. Meyer's compensation ranked 5,298th out of 14,666 executives tracked by ExecPay. In other words, Meyer earned more than 63.9% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 5,298 out of 14,666 | 64th |
Division Manufacturing | 1,892 out of 5,768 | 67th |
Major group Chemicals And Allied Products | 563 out of 2,074 | 73rd |
Industry group Drugs | 434 out of 1,730 | 75th |
Industry Pharmaceutical Preparations | 342 out of 1,329 | 74th |
Source: SEC filing on April 30, 2018.
Meyer's colleagues
We found two more compensation records of executives who worked with Colin J. Meyer at REATA PHARMACEUTICALS in 2017.
News
REATA PHARMACEUTICALS CEO J Huff's 2021 pay falls 37% to $4M
April 29, 2022
REATA PHARMACEUTICALS CEO J Huff's 2020 pay rises 15% to $6.4M
April 30, 2021
REATA PHARMACEUTICALS CFO Manmeet Soni receives $13M in 2019
April 29, 2020
REATA PHARMACEUTICALS CEO J Huff's 2018 pay falls 82% to $935K
April 30, 2019